Terms: = Ovarian cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Prognosis
260 results:
1. PURE vs. mixed clear cell ovarian carcinomas: Is there any impact on survival?
Güzel D; Terek C; Besler A; Serin G; Önal Z; Akman L; Göker E; Ali Şanli U; Zekioğlu O; Özdemir N; Özsaran A; Yildirim N
Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():321-326. PubMed ID: 38518487
[TBL] [Abstract] [Full Text] [Related]
2. A clinicopathological study about the epidemiology of granulosa cell tumors in Lebanon.
Yaacoub S; Hajj L; Khairallah A
BMC Cancer; 2024 Mar; 24(1):309. PubMed ID: 38448917
[TBL] [Abstract] [Full Text] [Related]
3. Platinum desensitization therapy and its impact on the prognosis of ovary high-grade serous adenocarcinoma: a real world-data.
Li K; Yin R
Front Immunol; 2024; 15():1346464. PubMed ID: 38312839
[TBL] [Abstract] [Full Text] [Related]
4. Low-grade endometrioid endometrial cancer with adnexal only metastasis: Evaluation of de-escalation of adjuvant therapy.
Matsuo K; Chen L; Neuman MK; Klar M; Roman LD; Wright JD
Eur J Cancer; 2024 Mar; 200():113533. PubMed ID: 38309016
[TBL] [Abstract] [Full Text] [Related]
5. Oncological and endocrinological outcomes for children and adolescents with testicular and ovarian sex cord-stromal tumors. Results of the TGM13 National Registry.
Fuentes C; Ouldbey Y; Orbach D; Sudour-Bonnange H; Verité C; Rome A; Dumesnil C; Thebaud E; Hameury F; Dijoud F; Chabaud S; Cote MD; Fresneau B; Faure-Conter C
Pediatr Blood Cancer; 2024 Apr; 71(4):e30864. PubMed ID: 38259036
[TBL] [Abstract] [Full Text] [Related]
6. Safety of fertility-sparing surgery in young women with stage I endometrioid epithelial and mucinous ovarian cancer: A population-based analysis.
Li J; Qiao H; Liu Y; Huang C; Cheng A; Lin Z; Wang L; Lu H
Eur J Surg Oncol; 2024 Jan; 50(1):107276. PubMed ID: 38064863
[TBL] [Abstract] [Full Text] [Related]
7. Anticipated time to seek medical advice for possible ovarian cancer symptoms and perceived barriers to early presentation among Palestinian women: a national cross-sectional study.
Elshami M; Al-Madhoun S; Alser M; Al-Slaibi I; Yaseen A; Tuffaha A; Jabr H; Ubaiat S; Khader S; Khraishi R; Jaber I; Arafeh ZA; Alqattaa A; Hadi AAE; Barhoush O; Hijazy M; Eleyan T; Alser A; Hziema AA; Shatat A; Almakhtoob F; Mohamad B; Farhat W; Abuamra Y; Mousa H; Adawi R; Musallam A; Albarqi SI; Abu-El-Noor N; Bottcher B
BMC Cancer; 2023 Oct; 23(1):975. PubMed ID: 37833659
[TBL] [Abstract] [Full Text] [Related]
8. PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer.
Chen B; Lu X; Zhou Q; Chen Q; Zhu S; Li G; Liu H
PLoS One; 2023; 18(8):e0290031. PubMed ID: 37582104
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic marker C3AR1 is associated with ovarian cancer cell proliferation and immunosuppression in the tumor microenvironment.
Huang J; Zhou L; Deng K
J Ovarian Res; 2023 Apr; 16(1):64. PubMed ID: 37005667
[TBL] [Abstract] [Full Text] [Related]
10. Clinical Relevance of Mortalin in ovarian cancer Patients.
Rajtak A; Czerwonka A; Pitter M; Kotarski J; Okła K
Cells; 2023 Feb; 12(5):. PubMed ID: 36899836
[No Abstract] [Full Text] [Related]
11. ovarian cancer prevention by opportunistic salpingectomy is a new de facto standard in Germany.
Runnebaum IB; Kather A; Vorwergk J; Cruz JJ; Mothes AR; Beteta CR; Boer J; Keller M; Pölcher M; Mustea A; Sehouli J
J Cancer Res Clin Oncol; 2023 Aug; 149(10):6953-6966. PubMed ID: 36847838
[TBL] [Abstract] [Full Text] [Related]
12. External Validation of the ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International ovarian Tumor Analysis 2-Step Strategy to Stratify ovarian Tumors Into O-RADS Risk Groups.
Timmerman S; Valentin L; Ceusters J; Testa AC; Landolfo C; Sladkevicius P; Van Holsbeke C; Domali E; Fruscio R; Epstein E; Franchi D; Kudla MJ; Chiappa V; Alcazar JL; Leone FPG; Buonomo F; Coccia ME; Guerriero S; Deo N; Jokubkiene L; Kaijser J; Scambia G; Andreotti R; Timmerman D; Bourne T; Van Calster B; Froyman W
JAMA Oncol; 2023 Feb; 9(2):225-233. PubMed ID: 36520422
[TBL] [Abstract] [Full Text] [Related]
13. Recurrence and survival in endometrioid endometrial cancer - a population-based cohort study.
Åkesson Å; Adok C; Dahm-Kähler P
Gynecol Oncol; 2023 Jan; 168():127-134. PubMed ID: 36434947
[TBL] [Abstract] [Full Text] [Related]
14. Clinical calculator redefines prognosis for high-risk early-stage ovarian cancers and potential to guide treatment in the adjuvant setting.
Bui A; Gehrig PA; Ghamande S; Rungruang BJ; Chan JK; Mysona DP
Gynecol Oncol; 2022 Nov; 167(2):205-212. PubMed ID: 36055814
[TBL] [Abstract] [Full Text] [Related]
15. Embryonal Rhabdomyosarcoma of the Uterine Cervix: A Clinicopathologic Study of 94 Cases Emphasizing Issues in Differential Diagnosis Staging, and Prognostic Factors.
Devins KM; Young RH; Ghioni M; Burandt E; Bennett JA; Oliva E
Am J Surg Pathol; 2022 Nov; 46(11):1477-1489. PubMed ID: 35941719
[TBL] [Abstract] [Full Text] [Related]
16. In-hospital prognosis of malignancy-related pulmonary embolism: an analysis of the national inpatient sample 2016-2018.
Park DY; An S; Kashoor I; Ezegwu O; Gupta S
J Thromb Thrombolysis; 2022 Nov; 54(4):630-638. PubMed ID: 35876942
[TBL] [Abstract] [Full Text] [Related]
17. Performance Analysis of ovarian cancer Detection and Classification for Microarray Gene Data.
Kalaiyarasi M; Rajaguru H
Biomed Res Int; 2022; 2022():6750457. PubMed ID: 35872866
[TBL] [Abstract] [Full Text] [Related]
18. Clinicopathological features, prognosis, and fertility outcomes in Chinese Han women treated for ovarian yolk sac tumor: A retrospective case series study from two tertiary-care academic medical centers.
Qin L; Wang B; Wang Z; He D
Medicine (Baltimore); 2022 Jul; 101(29):e29868. PubMed ID: 35866762
[TBL] [Abstract] [Full Text] [Related]
19. Nestin as a Prognostic Biomarker in High-grade Epithelial ovarian cancer Treated by Neoadjuvant Chemotherapy.
Veyssière H; Aldarazi G; Molnar I; Durando X; Radosevic-Robin N
Anticancer Res; 2022 Jul; 42(7):3583-3594. PubMed ID: 35790290
[TBL] [Abstract] [Full Text] [Related]
20. Genomic Determinants of Early Recurrences in Low-Stage, Low-Grade Endometrioid Endometrial Carcinoma.
Safdar NS; Stasenko M; Selenica P; Martin AS; da Silva EM; Sebastiao APM; Krystel-Whittemore M; Abu-Rustum NR; Reis-Filho JS; Soslow RA; Shen R; Mueller JJ; Oliva E; Weigelt B
J Natl Cancer Inst; 2022 Nov; 114(11):1545-1548. PubMed ID: 35699480
[TBL] [Abstract] [Full Text] [Related]
[Next]
